Month: March 2023

Winnebago Industries to Acquire Premier Lithium-ion Battery Solutions Provider Lithionics Battery

Written by Customer Service on March 27, 2023. Posted in Mergers And Acquisitions.

Advances Winnebago Industries’ strategic innovation and electric solutions platforms with new technological and engineering capabilities EDEN PRAIRIE, Minn., March 27, 2023 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today announced that it has reached a definitive agreement to acquire Lithionics Battery (“Lithionics”), a lithium-ion battery solutions provider to recreational equipment and specialty vehicle markets. The addition of Lithionics will provide Winnebago Industries with enhanced technological and engineering capabilities to offer consumers more differentiated products with innovative electrical solutions, as well as bring strategic sourcing benefits and secure a critical area of its supply chain. Terms of the deal were not disclosed. Founded in 2010, Lithionics...

Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

– Fast Track Designation granted to TNG462, next-generation MTA-Cooperative PRMT5 inhibitor – – Adam Crystal, M.D., Ph.D. appointed President of Research and Development – BOSTON, March 27, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported its financial results for the fourth quarter and full year ended December 31, 2022, and provided business highlights. “2022 was an important year for Tango, as we made critical strides in advancing our programs. We advanced our pipeline of precision oncology programs with the addition of three synthetic lethal development candidates and most importantly, initiated the clinical trial of our lead program, TNG908. We also continued to buildout...

Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2022 and Business Highlights

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

INTERCEPT-AD, a Phase 1 clinical trial of ACU193 in patients with early Alzheimer’s disease, completed enrollment in February 2023Topline data expected in the third quarter of 2023Cash, cash equivalents and marketable securities of $193.4 million as of Dec. 31, 2022 expected to be sufficient to support clinical and operational goals through 2025Company to host conference call and webcast today at 8:00 a.m. ETCHARLOTTESVILLE, Va. and CARMEL, Ind., March 27, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) and is designed for the treatment of Alzheimer’s disease (AD), today reported financial results for the full year ended December 31, 2022 and provided a business...

Nexalin Technology Provides 2022 Year-End Business Update

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today provided a business update for the year ended December 31, 2022. Mark White, CEO of Nexalin Technology stated, “Nexalin has made significant progress towards commencing clinical trials of our Gen-2 and Gen-3 neurostimulation devices in the United States. Nexalin’s enhanced neurostimulation devices combine innovation, frequencies and algorithms to provide an unprecedented solution for treating mental health disorders without the need for medication. Although our Gen-1 device was previously cleared by the U.S. Food and Drug Administration (FDA) to treat patients with anxiety, depression, and insomnia, we believe that the new devices will allow deeper penetration into the brain and provide enhanced patient response...

Tempo Automation Announces Definitive Agreement to Acquire Optimum Design Associates Extending Its Accelerated Manufacturing Platform to Electronic Design Services

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) — Tempo Automation Holdings, Inc. (NASDAQ: TMPO, “Tempo Automation” or “Tempo”), a leading software-accelerated electronics manufacturer, announced today that it has entered into a definitive agreement to acquire Optimum Design Associates, Inc. and Optimum Design Associates Pty. Ltd. (collectively “Optimum” or “Optimum Design Associates”), a fast-growing electronic design services company with offices in the United States and Australia that has delivered over 10,000 printed circuit board (PCB) designs to blue-chip customers. By vertically integrating electronic design and manufacturing, Tempo expects to be able to engage with customers even earlier in their product design process, streamlining the hardware development journey and providing a more efficient and faster way to get electronic...

Venus Concept Announces Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Revenue Guidance

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

TORONTO, March 27, 2023 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Summary & Recent Highlights:Total revenue of $24.3 million, down $8.3 million, or 26%, year-over-year; up $2.7 million, or 13% quarter-over-quarter.U.S. revenue down 14% year-over-year; up 17% quarter-over-quarter. Cash system revenue represented approximately 71% of total systems and subscriptions revenue, compared to 60% in the prior year period.GAAP net loss attributable to stockholders of $9.9 million, compared to GAAP net loss attributable to stockholders of $4.3 million last year. Adjusted EBITDA loss of $6.3 million, compared to Adjusted EBITDA loss...

Augmedix Reports Strong Commercial Traction and Sales Momentum; Reports Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) — Augmedix (Nasdaq: AUGX), a leading provider of ambient medical documentation and data solutions delivered remotely to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and 12 months ended December 31, 2022. “We finished 2022 with our best-ever fourth quarter in terms of bookings, with sales momentum continuing into 2023 with record first-quarter bookings, including our largest-ever clinician cohort signed,” said Manny Krakaris, Chief Executive Officer at Augmedix. “Our expanding portfolio of products has positioned us well for the large market opportunity in front of us, and we look forward to delivering strong results in 2023 with improving operating leverage.” Continued Krakaris, “Our innovative technology...

FitLife Brands Announces Fourth Quarter and Full Year 2022 Results

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

Omaha, March 27, 2023 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company”) (OTC Pink: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the year ended December 31, 2022. Highlights for the year ended December 31, 2022 include:Total revenue was $28.8 million, an increase of 3.2% compared to $27.9 million in the prior year. Revenue for the fourth quarter was adversely affected by the timing of wholesale shipments, as explained further below. Online sales for the full year increased 23.2% to $8.2 million, representing 28% of total revenue compared to 24% in the prior year. For the fourth quarter, online sales increased 22.2% and accounted for 37% of total revenue compared to 23% during the same period in 2021. Gross profit declined...

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.21 per Share for Q1 2023

Written by Customer Service on March 27, 2023. Posted in Dividend Reports And Estimates.

HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today a quarterly distribution of $0.21 per share for the fiscal quarter ended February 28, 2023. This distribution, which is an increase of $0.01 per share over the prior distribution (a 5% increase), is payable to common stockholders on April 17, 2023 (as outlined in the table below).Ex-Date Record Date Payment Date Distribution Amount Return of Capital Estimate(1)4/6/23 4/10/23 4/17/23 $0.21 20%(1) This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of the fiscal year and may differ substantially from this preliminary information.Kayne Anderson Energy Infrastructure...

Kayne Anderson NextGen Energy & Infrastructure Announces Distribution of $0.16 per Share for Q1 2023

Written by Customer Service on March 27, 2023. Posted in Dividend Reports And Estimates.

HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) announced today a quarterly distribution of $0.16 per share for the fiscal quarter ended February 28, 2023. This distribution is payable to common stockholders on April 17, 2023 (as outlined in the table below).Ex-Date Record Date Payment Date Distribution Amount Return of CapitalEstimate(1)4/6/23 4/10/23 4/17/23 $0.16 80%(1) The return of capital estimate is based on the Funds anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of the fiscal year and may differ substantially from this preliminary information.Kayne Anderson NextGen Energy & Infrastructure, Inc. (NYSE: KMF) is a non-diversified, closed-end...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals